278 related articles for article (PubMed ID: 30401978)
1. Statins attenuate outgrowth of breast cancer metastases.
Beckwitt CH; Clark AM; Ma B; Whaley D; Oltvai ZN; Wells A
Br J Cancer; 2018 Oct; 119(9):1094-1105. PubMed ID: 30401978
[TBL] [Abstract][Full Text] [Related]
2. Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition.
Taylor DP; Clark A; Wheeler S; Wells A
Breast Cancer Res Treat; 2014 Apr; 144(3):551-60. PubMed ID: 24610032
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin facilitates chemotherapy effects in metastatic triple-negative breast cancer.
Marti JLG; Beckwitt CH; Clark AM; Wells A
Br J Cancer; 2021 Oct; 125(9):1285-1298. PubMed ID: 34462586
[TBL] [Abstract][Full Text] [Related]
4. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
[TBL] [Abstract][Full Text] [Related]
5. Modeling the Complexity of the Metastatic Niche Ex Vivo.
Clark AM
Methods Mol Biol; 2021; 2258():221-239. PubMed ID: 33340364
[TBL] [Abstract][Full Text] [Related]
6. Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling.
Beckwitt CH; Shiraha K; Wells A
PLoS One; 2018; 13(5):e0197422. PubMed ID: 29763460
[TBL] [Abstract][Full Text] [Related]
7. Preparation of biocompatible copolymeric micelles as a carrier of atorvastatin and rosuvastatin for potential anticancer activity study.
Hamidreza Kheiri M; Alimohammadi N; Danafar H
Pharm Dev Technol; 2019 Mar; 24(3):303-313. PubMed ID: 29741465
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen-bonded and reduction-responsive micelles loading atorvastatin for therapy of breast cancer metastasis.
Xu P; Yu H; Zhang Z; Meng Q; Sun H; Chen X; Yin Q; Li Y
Biomaterials; 2014 Aug; 35(26):7574-87. PubMed ID: 24899527
[TBL] [Abstract][Full Text] [Related]
9. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a.
Wolfe AR; Debeb BG; Lacerda L; Larson R; Bambhroliya A; Huang X; Bertucci F; Finetti P; Birnbaum D; Van Laere S; Diagaradjan P; Ruffell B; Trenton NJ; Chu K; Hittelman W; Diehl M; Levental I; Ueno NT; Woodward WA
Breast Cancer Res Treat; 2015 Dec; 154(3):495-508. PubMed ID: 26590814
[TBL] [Abstract][Full Text] [Related]
11. Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cells.
Yang M; Ma B; Shao H; Clark AM; Wells A
BMC Cancer; 2016 Jul; 16():419. PubMed ID: 27387344
[TBL] [Abstract][Full Text] [Related]
12. Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells.
Mueck AO; Seeger H; Wallwiener D
Menopause; 2003; 10(4):332-6. PubMed ID: 12851516
[TBL] [Abstract][Full Text] [Related]
13. The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.
Xu K; Tian X; Oh SY; Movassaghi M; Naber SP; Kuperwasser C; Buchsbaum RJ
Breast Cancer Res; 2016 Jan; 18(1):14. PubMed ID: 26821678
[TBL] [Abstract][Full Text] [Related]
14. Fludioxonil induced the cancer growth and metastasis via altering epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in cellular and xenografted breast cancer models.
Go RE; Kim CW; Jeon SY; Byun YS; Jeung EB; Nam KH; Choi KC
Environ Toxicol; 2017 Apr; 32(4):1439-1454. PubMed ID: 27539251
[TBL] [Abstract][Full Text] [Related]
15. Taxifolin inhibits breast cancer cells proliferation, migration and invasion by promoting mesenchymal to epithelial transition via β-catenin signaling.
Li J; Hu L; Zhou T; Gong X; Jiang R; Li H; Kuang G; Wan J; Li H
Life Sci; 2019 Sep; 232():116617. PubMed ID: 31260685
[TBL] [Abstract][Full Text] [Related]
16. Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth.
Weidenfeld K; Schif-Zuck S; Abu-Tayeh H; Kang K; Kessler O; Weissmann M; Neufeld G; Barkan D
Oncotarget; 2016 Nov; 7(44):71362-71377. PubMed ID: 27655685
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin preferentially inhibits the growth of high ZEB-expressing canine cancer cells.
Ishikawa T; Osaki T; Sugiura A; Tashiro J; Warita T; Hosaka YZ; Warita K
Vet Comp Oncol; 2022 Mar; 20(1):313-323. PubMed ID: 34657361
[TBL] [Abstract][Full Text] [Related]
18. A liver microphysiological system of tumor cell dormancy and inflammatory responsiveness is affected by scaffold properties.
Clark AM; Wheeler SE; Young CL; Stockdale L; Shepard Neiman J; Zhao W; Stolz DB; Venkataramanan R; Lauffenburger D; Griffith L; Wells A
Lab Chip; 2016 Dec; 17(1):156-168. PubMed ID: 27910972
[TBL] [Abstract][Full Text] [Related]
19. Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis.
Li D; Wang H; Ding Y; Zhang Z; Zheng Z; Dong J; Kim H; Meng X; Zhou Q; Zhou J; Fang L; Shen Q
Cancer Lett; 2018 Jun; 424():97-108. PubMed ID: 29580806
[TBL] [Abstract][Full Text] [Related]
20. Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma.
Erin N; Kale S; Tanrıöver G; Köksoy S; Duymuş O; Korcum AF
Breast Cancer Res Treat; 2013 Jun; 139(3):677-89. PubMed ID: 23760857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
